Effect of Coconut Milk Supplementation to Improve Nutritional Status in Cirrhosis Patient
NCT03354299 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2017-11-27
Summary
Liver cirrhosis still becomes a major issue in Indonesia. Malnutrition has been observed in liver cirrhosis patients as it deteriorates liver function and cirrhosis itself. Malnutrition in liver cirrhosis can increase morbidity and mortality rates.
Patients with liver cirrhosis have increased energy expenditure and endogenous fat oxidation reaction which is used as the basic energy sources. Energy obtained from fat was accounted for 86% of the total energy sources in this population. Fatty acid is also known to be an efficient energy backup for hepatocytes and other cells because it generates higher adenosine triphosphate (ATP) than other sources.
Supplementary diet for patients with liver cirrhosis is considered beneficial for preventing hypercatabolism. To fulfill their nutritional needs, patients with liver cirrhosis is advised to take an extra food, such as a late night snack (LNS) with a total carbohydrate of around 50 g (equivalent to 200 kkal). Considering that most of the energy source in patients with liver cirrhosis came from fat, so the additional sources of energy having a high fat content were considered to be potentially highly beneficial to address the patients' nutritional status, as well as to reduce the risk of hyperglycemia after a meal and hypoglycemia after a long night fasting period time.
Coconut milk contains many saturated fatty acids belonging to the medium chain triacylglycerol (MCT) group. The characteristics of MCT are quite different from long chain triacylglycerol (LCT). MCTs are more easily absorbed than LCTs, and are mostly absorbed in the form of free fatty acids, in both healthy and liver cirrhosis populations.
This study wants to investigate the effects of coconut milk supplementation on improving the nutritional status of patients with liver cirrhosis. The patients were divided into 2 groups, groups I received 25 g of sugar plus 50 cc of coconut milk (200 kkal) as late night snacks (LNS); and group II received 50 g of sugar alone (200 kkal) as LNS. Investigators think that the group who received coconut milk supplementation has better nutritional status than the other group.
Conditions
- Malnutrition
- Cirrhosis, Liver
Interventions
- DIETARY_SUPPLEMENT
-
coconut milk
50 cc of coconut milk supplementation plus 25 gram sugar (pudding) was given to cirrhosis patients as late night snack
Sponsors & Collaborators
-
Dr Cipto Mangunkusumo General Hospital
lead OTHER
Principal Investigators
-
Rino A Gani, PhD · Dr
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2014-07-31
- Completion
- 2015-03-31
Countries
- Indonesia
Study Locations
More Related Trials
-
THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.
NCT02381769 ·Status: COMPLETED ·Phase: NA
-
High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease
NCT05578404 ·Status: COMPLETED ·Phase: PHASE2
-
Magnesium in Liver Cirrhosis
NCT01894867 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD
NCT05897606 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.
NCT03161106 ·Status: WITHDRAWN ·Phase: NA
-
Selenium Supplementation of Patients With Cirrhosis
NCT00212186 ·Status: COMPLETED ·Phase: NA
-
Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects
NCT01002261 ·Status: COMPLETED
-
Zinc Supplementation in Alcoholic Cirrhosis
NCT02072746 ·Status: COMPLETED ·Phase: NA
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
Chia Supplementation and Non Alcoholic Fatty Liver Disease
NCT03942822 ·Status: COMPLETED ·Phase: NA
-
Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy
NCT01113567 ·Status: TERMINATED ·Phase: NA
-
Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study
NCT02366052 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy
NCT06072521 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life
NCT01008293 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study
NCT02520817 ·Status: COMPLETED
-
S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE
NCT01446523 ·Status: COMPLETED ·Phase: NA
-
Affect of Melatonin on Sleep and Cognition in Cirrhosis
NCT07046429 ·Status: RECRUITING ·Phase: NA
-
Synbiotics Interventions for Managing Cirrhosis and Its Complications
NCT05687409 ·Status: COMPLETED ·Phase: PHASE4
-
Selenium Supplementation of Patients With Cirrhosis
NCT00212212 ·Status: TERMINATED ·Phase: NA
-
Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease
NCT02690792 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Phosphatidylcholine in NAFLD
NCT04411862 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life
NCT00375375 ·Status: COMPLETED ·Phase: PHASE4
-
Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
NCT02715973 ·Status: COMPLETED ·Phase: NA
-
Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy
NCT02022137 ·Status: COMPLETED ·Phase: NA
-
Quality of Life and Nutritional Improvements in Cirrhotic Patients
NCT01842113 ·Status: TERMINATED ·Phase: PHASE4